Eva Aubets Gil

Eva Aubets Gil is an Associate Director and Patient Safety Scientist in Oncology at AstraZeneca, with a PhD in Biomedicine and a PharmD. They have four years of experience focusing on cancer and gene modulation therapies, contributing to the validation of a novel gene silencing tool and the development of delivery strategies. Previously, Eva held positions such as Senior Drug Safety Pharmacology & Toxicology Analyst at Clarivate and Manager, Patient Safety Scientist at AstraZeneca. Their educational background includes multiple advanced degrees from the University of Barcelona and CEU Cardenal Herrera University.